Abstract:Objective To investigate the role of calcium/calmodulin-dependent protein kinase Ⅱ (CaMK Ⅱ) in the primary somatosensory area (S1 area) and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats.Methods One hundred fifty-six male Sprague-Dawley rats,aged 8-10 weeks,weighing 240-260 g,were randomly allocated into 4 groups using a radom number table:control group (group C,n=6),remifentanil group (group R,n=50),lidocaine group (group L,n=50),and remifentanil+lidocaine group (group RL,n =50).Remifentanil was given as a bolus of 6 mg/kg followed by an 2 h infusion of 2.4 μg · kg-1 · min-1 in group R.Lidocaine was given as a bolus of 6 mg/kg followed by an infusion of 200 μg · kg-1 · min-1 for 2 h in group L.In group RL,drug administration was similar to those previously described in R and L groups.The mechanical paw withdrawal threshold (MWT) and thermal paw withdrawal latency (TWL) were measured before administration and at 0.5,2,5 and 24 h after the end of administration.The rats were then sacrificed immediately after administration and at 0.5,2,5 and 24 h after the end of administration in R,L and RL groups,or at the corresponding time point in group C.The S1 area and hippocampi were isolated for determination of phosphorylated CaMK Ⅱ (p-CaMK Ⅱ) expression by Western blot.Results Compared with the value before administration,the MWT was significantly decreased at 0.5 and 2 h after the end of administration (P＜0.05),and no significant change was found in TWL at each time point after the end of administration in R,L and RL groups (P＞0.05).Compared with group C,p-CaMK Ⅱ expression in the S1 area and hippocampi was significantly up-regulated immediately after administration and at 0.5 and 2 h after the end of administration in group R (P＜0.05).Compared with group R,p-CaMK Ⅱ expression in the S1 area and hippocampi was significantly down-regulated immediately after administration and at 0.5 and 2 h after the end of administration in group RL,and p-CaMK Ⅱ expression in the S1 area was significantly down-regulated immediately after administration,and at 0.5 and 2 h after the end of administration,and p-CaMK Ⅱ expression in the hippocampi was down-regulated immediately after administration,and at 0.5,2 and 24 h after the end of administration in group L,and MWT was increased at 0.5 and 2 h after the end of administration in groups L and RL (P＜0.05).There was no significant difference in TWL at each time point among the three groups (P＞0.05).Conclusion The mechanism by which lidocaine mitigates remifentanil-induced hyperalgesia is associated with inhibited activity of CaMKII in the S1 area and hippocampi of rats.

Influence of dexmedetomidine on expressions of PKCγ, CaMKⅡαand pCaMKⅡαin spinal cord in rats with hyperalgesia

Dezocine Attenuates the Remifentanil-Induced Postoperative Hyperalgesia by Inhibition of Phosphorylation of CaMKⅡα.

Effect of Dexmedetomidine on Trafficking of N-methyl-D-aspartate Receptors in Spinal Dorsal Hornneurons During Remifentanil-Induced Hyperalgesia in Rats with Incisional Pain

Effects of Dexmedetomidine on Remifentanil-Induced Hyperalgesia in a Rat Model of Incisional Pain

Relationship Between Delta Opioid Receptors and Activity of Glycogen Synthase Kinase-3Β in Spinal Cord During Hyperalgesia Induced by Remifentanil in a Rat Model of Incisional Pain

Changes in expression of PICK1 in spinal cord and dorsal root ganglion neurons during remifentanil-induced hyperalgesia in rats with incisional pain

Prevention of Remifentanil Induced Postoperative Hyperalgesia by Dexmedetomidine Via Regulating the Trafficking and Function of Spinal NMDA Receptors As Well As PKC and CaMKII Level in Vivo and in Vitro

Ketamine Reduces Remifentanil-Induced Postoperative Hyperalgesia Mediated by CaMKII-NMDAR in the Primary Somatosensory Cerebral Cortex Region in Mice.

The Influence of Ketamine on KCC2 in Spinal Cord of Rat in Remifentanil-Induced Hyperalgesia

Effects of CaMK Ⅱ Inhibitor KN93 on Remifentanil-Induced Hyperalgesia

Effect of Dexmedetomidine on Expression of C-Fos Protein in Dorsal Root Ganglion Neurons in a Rat Model of Neuropathic Pain

Dexmedetomidine Prevents Remifentanil-Induced Postoperative Hyperalgesia and Decreases Spinal Tyrosine Phosphorylation of N-methyl-d-aspartate Receptor 2B Subunit.

Role of Spinal Protein Kinase C in Remifentanil-Induced Hyperalgesia in Rats with Incisional Pain: the Relationship with Phosphorylation of NR1

Role of Glycogen Synthase Kinase-3Β in Trafficking of NR1-containing N-methyl-D-aspartate Receptor and NR2B-containing N-methyl-D-aspartate Receptor in Spinal Cord in Rats with Incisional Pain and Remifentanil-Induced Hyperalgesia

Analgesic Effcacy and Spinal Neurotoxicity of Intrathecal Different Doses of Dexmedetomidine in Rats

Effects of Remifentanil on the Expression of Inducible Nitric Oxide Synthase Mrna and C-FOS Protein in Spinal Cord of Rats with Incision Pain

Effect of Dexmedetomidine on Remifentanil-Induced Miniature Excitatory Postsynaptic Currents Mediated by NMDA Receptors in Spinal Dorsal Horn Neurons of Rats

Phosphorylated CaMKII Levels Increase in Rat Central Nervous System after Large-Dose Intravenous Remifentanil

PKCε Contributes to Remifentanil-Induced Hyperalgesia Via Downregulating Mu-Opioid Receptor in Rat Dorsal Root Ganglion Neurons

Role of CaMK Ⅱ in primary somatosensory area and hippocampi in reduction of remifentanil-induced hyperalgesia by lidocaine in rats

Changes in Expression of TRPV1 in Dorsal Root Ganglions During Remifentanil-Induced Hyperalgesia in Rats with Incisional Pain